15 results
10-K
2020 FY
ONCR
Oncorus, Inc.
10 Mar 21
Annual report
4:12pm
transferred our processes to commercial CMOs based in the United States for production, labeling, packaging and distribution of our initial batches of clinical … . The FDCA, PHSA and their corresponding regulations govern, among other things, the testing, manufacturing, safety, efficacy, labeling, packaging
424B4
ONCR
Oncorus, Inc.
12 Feb 21
Prospectus supplement with pricing info
4:23pm
, including requirements related to the manufacturing processes, post-approval clinical data, labeling, packaging, distribution, adverse event reporting … that a labeling instruction is required in product packaging recommending that combination, we could be accused of, or held liable for, infringement
DRS
ONCR
Oncorus, Inc.
28 Jan 21
Draft registration statement
12:00am
, packaging, distribution, adverse event reporting, storage, recordkeeping, export, import, advertising, marketing, and promotional activities … or a sublicense. In the event that a labeling instruction is required in product packaging recommending that combination, we could be accused of, or held liable
10-Q
3u4l7ez49m6x zlwzc6p
12 Nov 20
Quarterly report
8:01am
424B4
a7201mbnex7nnw
2 Oct 20
Prospectus supplement with pricing info
12:00am
S-1
EX-10.17
mib3m0ehozrht4 903t
11 Sep 20
IPO registration
4:49pm
S-1
yvae775gf3
11 Sep 20
IPO registration
4:49pm
DRS/A
zbuck4bi up
26 Aug 20
Draft registration statement (amended)
12:00am
DRS/A
dsx9g0x5
29 Jul 20
Draft registration statement (amended)
12:00am
DRS/A
wdtkwwr0cqgemd4
20 Dec 19
Draft registration statement (amended)
12:00am
DRS
EX-10.17
l0fo e8toi23
31 Oct 19
Draft registration statement
12:00am
DRS
e2x1g
31 Oct 19
Draft registration statement
12:00am
- Prev
- 1
- Next